ArticlePharmaceutical biology2024

Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial-mesenchymal transition in triple-negative breast cancer.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.